Devin A, Cook A, Lin Y, Rodriguez Y, Kelliher M, Liu Z
Department of Cell and Cancer Biology, Medicine Branch, Division of Clinical Sciences, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
Immunity. 2000 Apr;12(4):419-29. doi: 10.1016/s1074-7613(00)80194-6.
The death domain kinase RIP and the TNF receptor-associated factor 2 (TRAF2) are essential effectors in TNF signaling. To understand the mechanism by which RIP and TRAF2 regulate TNF-induced activation of the transcription factor NF-kappaB, we investigated their respective roles in TNF-R1-mediated IKK activation using both RIP-/- and TRAF2-/- fibroblasts. We found that TNF-R1-mediated IKK activation requires both RIP and TRAF2 proteins. Although TRAF2 or RIP can be independently recruited to the TNF-R1 complex, neither one of them alone is capable of transducing the TNF signal that leads to IKK activation. Moreover, we demonstrated that IKK is recruited to the TNF-R1 complex through TRAF2 upon TNF treatment and that IKK activation requires the presence of RIP in the same complex.
死亡结构域激酶RIP和肿瘤坏死因子受体相关因子2(TRAF2)是肿瘤坏死因子(TNF)信号传导中的关键效应分子。为了了解RIP和TRAF2调节TNF诱导转录因子NF-κB激活的机制,我们利用RIP基因敲除和TRAF2基因敲除的成纤维细胞,研究了它们在TNF-R1介导的IKK激活中的各自作用。我们发现,TNF-R1介导的IKK激活需要RIP和TRAF2蛋白。虽然TRAF2或RIP可以独立地被招募到TNF-R1复合物中,但它们单独任何一个都不能转导导致IKK激活的TNF信号。此外,我们证明,在TNF处理后,IKK通过TRAF2被招募到TNF-R1复合物中,并且IKK激活需要同一复合物中存在RIP。